U.S. Online Retail and Ecommerce Stock News

EyePoint Pharmaceuticals (EYPT) has recently caught investor attention as its shares moved slightly higher, following a period of noticeable volatility. The company’s performance has shifted over the past month, providing an interesting setup for those watching the healthcare space. See our latest analysis for EyePoint Pharmaceuticals. EyePoint’s shares have swung notably in recent weeks, and while the latest 1-day move was modest, momentum is still in play. The year-to-date share price...

Equinix recently appointed Douglas Merrill as Chief Information Security Officer and welcomed Rebecca Kujawa to its Board, both moves emphasizing enterprise technology leadership and governance expertise. Merrill's extensive background in cybersecurity and Kujawa's experience in energy infrastructure and digital transformation signal Equinix’s intention to further strengthen operational resilience and oversight as digital demands evolve. We will now explore how the addition of a proven...

On October 29, 2025, Autoliv, Inc. issued EUR 300 million in notes due 2030 at a 3.000% coupon, with proceeds allocated to projects supporting clean transportation, renewable energy, energy efficiency, and de-carbonization of operations and products. This financing marks a clear push by Autoliv to integrate sustainability objectives into its capital raising strategy, targeting both environmental impact and long-term business growth. We'll now assess how Autoliv's sustainable bond issuance...

Commercial Metals (CMC) shares have been navigating a mixed patch, with recent price moves showing modest declines over the past week and month. However, there has been a gain of 6% in the past 3 months. Investors are weighing these changes against the company’s performance metrics and longer-term growth. See our latest analysis for Commercial Metals. Commercial Metals’ share price has gained momentum this year, posting a strong year-to-date share price return of nearly 17%. However, the...

Piedmont Realty Trust released its third quarter and year-to-date 2025 earnings, reporting third quarter sales of US$133.03 million and a net loss of US$13.46 million, slightly higher than the prior year period. While the company saw a modest dip in revenue, its year-to-date net loss narrowed compared to the previous year, signaling some improvement despite ongoing challenges. We'll examine how the narrowing year-to-date net loss impacts Piedmont Realty Trust's overall investment narrative...

OGE Energy (OGE) stock has caught some attention lately, and investors may be wondering what is driving recent moves. Let’s take a closer look at the company’s performance and see how it stacks up right now. See our latest analysis for OGE Energy. OGE Energy’s share price has been relatively stable after a good run earlier this year, pausing at $44.08 following a modest pullback over the past month. The company’s total shareholder return sits at 8.7% for the past year and an impressive 68%...

Celanese Corporation recently reported third-quarter earnings, disclosing sales of US$2,419 million and a net loss of US$1.36 billion compared to net income of US$113 million in the same period last year. The earnings release followed news of Celanese’s intention to close its acetate tow facility in Lanaken, reflecting broader cost optimization efforts in response to ongoing demand and regulatory pressures. We'll explore how the significant net loss and site closure reshape Celanese's...

Earlier this week, Rigel Pharmaceuticals reported third-quarter 2025 results with revenue rising to US$69.46 million and net income at US$27.9 million, and also raised its full-year revenue guidance to a range of approximately US$285–290 million. The updated financial outlook, along with consistently higher earnings per share, suggests a period of robust business performance and growing optimism about future prospects. With Rigel's revenue guidance increase reflecting strong quarterly...

Century Communities, Inc. recently announced multiple new home community launches across Arizona, Florida, and Indiana under its Century Complete brand, along with the Board's declaration of a US$0.29 per share quarterly dividend payable on December 10, 2025, to stockholders of record as of November 26, 2025. The accelerated rollout of affordably priced homes with modern amenities and the ongoing commitment to regular shareholder dividends highlight the company’s focus on broadening its...

Privia Health Group (PRVA) just released its third-quarter earnings, showing strong year-over-year growth in both revenue and profits. The company also raised its revenue outlook for the full year, signaling confidence in ongoing performance. See our latest analysis for Privia Health Group. Following the upbeat earnings report and raised revenue guidance, Privia Health Group’s 16.5% share price return over the last 90 days stands out, even as the 1-year total shareholder return sits at 6.4%...

Coca-Cola (KO) has grabbed attention recently, with its stock posting steady gains over the past month. Investors seem to be taking note of its long-term performance and underlying fundamentals as a key focus at this time. See our latest analysis for Coca-Cola. Momentum for Coca-Cola has been building, with the stock’s 11.68% year-to-date share price return reflecting renewed optimism from investors. Over the past year, the company has delivered a total shareholder return of 11.75%, which...

Genius Sports (NYSE:GENI) announced a jump in third quarter revenue and at the same time increased its full year outlook, now targeting group revenue of around $655 million. This means 28% growth over last year. See our latest analysis for Genius Sports. Despite Genius Sports posting a quarterly net loss, the combination of robust revenue growth and a newly raised guidance has kept the narrative positive. Recent weeks have seen some short-term volatility, with a 1-day share price return of...

Resideo Technologies (REZI) has seen its stock move within a fairly tight range this month. This has drawn some attention from investors who are curious about the underlying factors. The company’s recent performance provides reason to take a closer look at its fundamentals. See our latest analysis for Resideo Technologies. Resideo Technologies' share price has swung sharply this month, but it still boasts a year-to-date price return of 37.45% and a one-year total shareholder return of 43.95%...

Ever wondered if Aurora Innovation is truly a hidden gem or just another name on the Nasdaq? If you have even a passing curiosity about finding value in fast-evolving tech stocks, you’ll want to read on. Despite some eye-catching long-term gains, with the stock up 141.7% over the past three years, recent momentum has been rough, with shares sliding 17.1% in just the last week and down 30.7% year-to-date. These moves come on the heels of notable updates in the autonomous driving sector and...

In recent news, PennyMac Mortgage Investment Trust has faced ongoing sales declines along with challenges related to net interest income and capital management during a difficult market cycle. This situation has prompted fresh concerns among investors about the company's operational health and its suitability for portfolio inclusion. We will examine how these persistent operational hurdles might influence PennyMac's investment narrative moving forward. This technology could replace...

On November 6, 2025, KeyCorp presented at The BancAnalysts Association of Boston Conference, where Chief Financial Officer Clark Harold Ibrahim Khayat and Head of Consumer Banking Victor B. Alexander discussed financial performance and strategy at The Langham Hotel in Boston. KeyCorp achieved a major financial turnaround in the third quarter of 2025, reporting revenues that more than doubled year-over-year and a return to profitability, outpacing analyst expectations even while facing...

Protagonist Therapeutics has announced that new clinical data on rusfertide in polycythemia vera, including results from the Phase 3 VERIFY study, will be presented at the 67th Annual ASH Meeting in December 2025. These presentations are expected to provide key insights into the durability, safety, and long-term effects of rusfertide treatment, which may be pivotal for future clinical and regulatory decisions. We'll explore how the forthcoming clinical evidence on rusfertide's durability and...

Earlier this week, NVR reported third-quarter earnings that surpassed analyst expectations, despite experiencing a 4% decrease in revenue and a 20% drop in net income compared to last year. This performance highlights the company's operational resilience amid a difficult housing market, further underscored by recent insider purchasing activity from board director Michael J. DeVito. We'll explore how NVR’s ability to outperform earnings expectations shapes its investment narrative in the...

Zenas BioPharma (ZBIO) just shared promising Phase 2 MoonStone trial results for obexelimab in Relapsing Multiple Sclerosis. This news could influence how investors view the pipeline's potential in autoimmune treatments. See our latest analysis for Zenas BioPharma. The market was quick to react to Zenas BioPharma’s MoonStone trial update, sending the share price up 6.3% in a single day and building on a powerful run that saw a 55.7% share price return over the past month. While the stock has...

Floor & Decor Holdings (NYSE:FND) attracted attention with its latest quarterly earnings release, showcasing higher sales and net income compared to last year. The announcement was accompanied by a planned CEO transition and updated guidance for the next fiscal year. See our latest analysis for Floor & Decor Holdings. Despite Floor & Decor’s solid revenue growth and plans for leadership continuity, the past year’s total shareholder return sits at -41.9%. Short-term momentum continues to fade,...

Illumina has captured fresh attention this week after delivering strong third quarter earnings and raising its full-year revenue outlook. The Chinese Ministry of Commerce's move to lift the export ban on Illumina products is also coming into focus. See our latest analysis for Illumina. Illumina’s week has been anything but quiet, with a powerful 22.3% seven-day share price return as investors respond to headline earnings and the positive turn in China’s regulatory stance. Despite recent...

Q2 Holdings (QTWO) reported a major milestone, turning profitable over the past year with earnings growing at an impressive 31.5% per year over the last five years. Looking ahead, earnings are forecast to surge 52.7% per year, easily beating the US market average growth rate of 15.8%. Revenue is expected to tick up 10.1% per year. With shares trading below estimated fair value at $70.17 but at a premium on a price-to-earnings basis, investors are weighing outsized growth forecasts and recent...

Sonoco Products (SON) has just completed the sale of its ThermoSafe business unit to Arsenal Capital Partners. This move aligns with the company’s strategy to streamline operations and focus on its core packaging businesses. See our latest analysis for Sonoco Products. Sonoco Products’ latest move to streamline its business with the ThermoSafe sale was a key factor behind recent market attention, with shares now trading at $40.45. Although the 1-year total shareholder return is down 17.3%,...

Light & Wonder (LNW) just released its third quarter results, showing higher revenue and net income compared to the same period last year. Alongside these improved numbers, the company completed a sizable buyback, reducing outstanding shares and potentially boosting shareholder value. See our latest analysis for Light & Wonder. After those solid results and the completion of its buyback, Light & Wonder’s share price jumped 8.5% in a day, helping to offset some of this year’s earlier declines...